Global H1N1 Infection Therapeutics Pipeline Report 2016 - Review of 37 Companies & Drug Profiles - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "H1N1 Infection - Pipeline Review, H1 2016" report to their offering.

This report provides comprehensive information on the therapeutic development for H1N1 Infection, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for H1N1 Infection and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

  1. Introduction
  2. H1N1 Infection Overview
  3. Therapeutics Development
  4. Pipeline Products for H1N1 Infection - Overview
  5. Pipeline Products for H1N1 Infection - Comparative Analysis
  6. H1N1 Infection - Therapeutics under Development by Companies
  7. H1N1 Infection - Therapeutics under Investigation by Universities/Institutes
  8. H1N1 Infection Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. H1N1 Infection - Products under Development by Companies
  13. H1N1 Infection - Products under Investigation by Universities/Institutes
  14. H1N1 Infection - Companies Involved in Therapeutics Development
  • Adamas Pharmaceuticals, Inc.
  • Akshaya Bio Inc.
  • Altimmune, Inc.
  • Antigen Express, Inc.
  • Beijing Minhai Biotechnology Co., Ltd
  • CEL-SCI Corporation
  • Cilian AG
  • CSL Limited
  • EpiVax, Inc.
  • Etubics Corporation
  • Gemmus Pharma Inc.
  • iBio, Inc.
  • ILiAD Biotechnologies, LLC
  • Inovio Pharmaceuticals, Inc.
  • Johnson & Johnson
  • Kineta, Inc.
  • Kyowa Hakko Kirin Co., Ltd.
  • Medicago Inc.
  • MedImmune, LLC
  • Microbiotix, Inc.
  • Mucosis B.V.
  • NanoViricides, Inc.
  • NewLink Genetics Corporation
  • Novavax, Inc.
  • OPKO Health, Inc.
  • PeptiDream Inc.
  • Sarepta Therapeutics, Inc.
  • Sirnaomics, Inc.
  • Takeda Pharmaceutical Company Limited
  • TechnoVax, Inc.
  • Theraclone Sciences, Inc.
  • Touchlight Genetics Limited
  • United Therapeutics Corporation
  • Vaxart, Inc.
  • Vironova AB

For more information visit http://www.researchandmarkets.com/research/r6jkkz/h1n1_infection

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Infectious Diseases Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Infectious Diseases Drugs